Nov 09, 2022 / 10:00PM GMT
Tiago Felipe Fauth - Crédit Suisse AG - Research Division - Research Analyst
All right. Welcome everyone to 31st Annual Healthcare Conference Credit Suisse. I'm Tiago Fauth, I'm a lead biotech analyst here at the bank. We're joined today by 23andMe. We have Joe and Kenneth, CFO and Chief Therapeutic Officer, respectively for our fireside chat. We will leave a few minutes towards the end if there are any questions. I'm going to start by admitting my bias. As a biotech analyst, I have to focus a little bit more on the therapeutic side, but hopefully, we'll cover a lot of ground here.
Questions and Answers:
Tiago Felipe Fauth - Crédit Suisse AG - Research Division - Research AnalystSo we can start with some broad remarks on where you guys stand today as a public entity. It's a fairly unique business model, kind of a hybrid. So where do you guys stand right now? What are some of the key business units or the way you segment your business and we'll dive right in after that.
Joseph Selsavage